eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Get Medicines Compendium UK app here

Wockhardt UK Ltd

Ash Road North, Wrexham Industrial Estate, Wrexham, LL13 9UF
Telephone: +44 (0)1978 661 261
Fax: +44 (0)1978 660 130

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Summary of Product Characteristics last updated on the eMC: 08/11/2011
SPC Ceftazidime 1g Powder for solution for injection

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 08/11/2011 and displayed until Current
Reasons for adding or updating:
  • Change to section 4.3 - Contraindications
  • Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
  • Change to section 4.8 - Undesirable Effects
  • Change to section 6.2 - Incompatibilities
Date of revision of text on the SPC:   01-Jul-2011
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company



Section 4.3

Deletion of the following text:

Ceftazidime constituted with lidocaine must never be used:

-          by the intravenous route

-          in infants under 30 months

-          in subjects with a previous history of hypersensitivity to this product

-          in patients who have an unpaced heart block

-          in patients with severe heart failure

 

Section 4.5

Deletion of the following text:

Ceftazidime does not interfere in the alkaline picrate assay for creatinine.

 

Section 4.8

Deletion – ‘lymphocytosis’

Addition – ‘Acute renal tubular necrosis’

-          hallucinations

 

Section 6.2

Addition:

In the absence of compatibility studies, this medicinal product must not be mixed with other medicinal products.

 

Updated on 01/09/2008 and displayed until 08/11/2011
Reasons for adding or updating:
  • New individual SPC (was previously included in combined SPC)
Date of revision of text on the SPC:  
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

None provided

Active Ingredients/Generics

 
   ceftazidime pentahydrate